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Abstract
Background: Recent evidence from prospective cohort studies show a relationship between consumption of dairy foods and 
cardiovascular diseases (CVDs) and type 2 diabetes mellitus (T2DM). This association highlights the importance of dairy foods 
consumption in prevention of these diseases and also reduction of associated healthcare costs. The aim of this study was to 
estimate avoidable healthcare costs of CVD and T2D through adequate dairy foods consumption in Iran. 
Methods: This was a multistage modelling study. We conducted a systematic literature review in PubMed and EMBASE to identify 
any association between incidence of CVD and T2DM and dairy foods intake, and also associated relative risks. We obtained 
age- and sex-specific dairy foods consumption level and healthcare expenditures from national surveys and studies. Patient level 
simulation Markov models were constructed to predict the disease incidence, patient population size and associated healthcare 
costs for current and optimal dairy foods consumption at different time horizons (1, 5, 10 and 20 years). All parameters including 
costs and transition probabilities were defined as statistical distributions in the models, and all analyses were conducted by 
accounting for first and second order uncertainty. 
Results: The systematic review results indicated that dairy foods consumption was inversely associated with incidence of T2DM, 
coronary heart disease (CHD) and stroke. We estimated that the introduction of a diet containing 3 servings of dairy foods per day 
may produce a $0.43 saving in annual per capita healthcare costs in Iran in the first year due to saving in cost of CVD and T2DM 
treatment. The estimated savings in per capita healthcare costs were $8.42, $39.97 and $190.25 in 5, 10 and 20-years’ time, 
respectively. Corresponding total aggregated avoidable costs for the entire Iranian population within the study time horizons were 
$33.83, $661.31, $3,138.21 and $14,934.63 million, respectively.
Conclusion: Our analysis demonstrated that increasing dairy foods consumption to recommended levels would be associated with 
reductions in healthcare costs. Further randomized trial studies are required to investigate the effect of dairy foods intake on cost 
of CVD and T2DM in the population. 
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Introduction
Healthcare costs have been growing rapidly over the 
last 3 decades in many countries including Iran, causing 
concern among governments, patients and insurance 
companies. Among the leading causes of  mortality in 
Iran are cardiovascular diseases (CVDs), diabetes and 
cancer, which account for more than 70% of  all deaths.1 
These diseases also impose a great burden on the 
country’s economy in terms of  healthcare costs and low 
productivity.2–4 These diseases account for almost half  of 
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total healthcare expenditure in all countries.5
Results from the Global Burden of  Disease (GBD) study 
show that unhealthy or poor diet is the leading risk factor 
for chronic diseases in many countries, including Iran.6 
But so far, little attention has been given to the possible 
effects of  dietary food intake modifications on the risk of 
developing one or more aforementioned chronic diseases 
and their related healthcare costs. Data published in the 
past 2 decades from randomized controlled trials (RCTs) 
and prospective studies suggest that dairy foods are 
among the main food groups that can be used to reduce 
the burden of  various medical conditions.7–16 Recent 
studies have shown that the dietary approaches to stop 
hypertension (DASH), a dietary pattern which is high in 
fruit, vegetables, nuts, fish, and low-fat dairy foods, can 
reduce blood pressure effectively, which may in part be 
attributed to its relatively high content of  low-fat dairy 
foods.7,17,18 The mechanisms by which dairy foods affect 
CVD incidence are diverse and include both positive 
and negative influences. Dairy foods are rich in protein 
(casein and whey), vitamins (riboflavin and vitamin B-12) 
and minerals (calcium, potassium, and magnesium) that 
can have beneficial effects on CVD.19 Saturated fat in 
dairy foods, on the other hand, can adversely influence 
coronary heart diseases (CHDs). In general, synthesis of 
the literature shows that dairy foods consumption may 
have protective effects on hypertension, CHD and stroke 
incidence.14,16,20–25 Recent studies suggest that there is also 
a significant inverse association between intakes of  dairy 
foods and type 2 diabetes mellitus (T2DM).10,11,26
Although dairy foods consumption, including milk, 
cheese, and yogurt, have been encouraged through the 
food-based dietary guidelines in Iran,27 results from recent 
studies show that most people in Iran do not consume 
enough dairy foods. Based on the updated dietary 
guideline recommended intakes of  dairy, including for 
those following a vegetarian eating pattern, are 3 daily 
servings for Americans nine and older, 2.5 servings for 
children ages 4 through 8 and 2 servings for children ages 
2 through 3 years old. The Mediterranean eating pattern 
calls for only 2 servings of  dairy for adults per day.28 
Special emphasis is placed on consuming more fat-free 
and low-fat milk and milk products in particular. Results 
from dietary surveys show that on average, people in Iran 
are consuming about 0.7 servings of  milk, 0.9 servings 
of  cheese and 1 servings of  yogurt per day.8,29,30 Dairy 
consumption decreases with age, and the gap between 
actual and recommended dairy consumption widens 
through adulthood with less than 1.5 dairy servings 
consumed by adults over the age of  50 years. 
A reduction in the incidence of  chronic diseases 
through adequate dairy consumption may improve 
population health and reduce healthcare costs. This 
may be considered improbable in the short term given 
the complex effects of  dietary risk factors on diseases 
incidence. But results from prospective cohort studies 
show a significant association between certain medical 
conditions and dairy consumption.7–9,16 Moreover, results 
from dose–response meta-analysis studies which provide 
vital information in judging the causal relationships 
when data from RCTs are sparse, suggest that the 
relationship between dairy consumption and T2DM and 
CVD are undeniable.10,11,20 Up to now, efforts to increase 
consumption of  dairy foods at the population-level have 
received little support from policy-makers. Unavailable 
or insufficient estimates of  the mortality and economic 
burden of  diseases due to low intake of  dairy foods 
can partly explain the lack of  attention to the above 
mentioned efforts. To address this important knowledge 
gap, we aimed to use the most recent epidemiological 
and economic data to estimate avoidable CVD and 
T2DM healthcare costs through increased dairy foods 
consumption. 
Methods
Study Design 
This is a modelling study and data from previous 
literature and national databases were used to present 2 
disease models to estimate avoidable T2DM and CVD 
healthcare costs. First, a systematic literature review was 
conducted to identify any association between different 
levels of  dairy foods consumption and incidence of  CVD 
and T2DM, using dose response meta-analysis studies. 
Second, we obtained age- and sex-specific dairy foods 
consumption statistics from national studies. Third, 
healthcare expenditures associated with CVD and T2DM 
were obtained from national studies and health system 
registries. Finally, using all data from previous steps as 
well as other epidemiological data, a Markov model for 
each disease was constructed to estimate avoidable direct 
healthcare costs of  CVD and T2DM through increased 
dairy consumption to optimum level (Figure 1). Below 
we have described details of  the methods used in each 
step. 
Step 1: Identification of  Diseases Related to Dairy 
Consumption 
We conducted a systematic literature review to identify 
studies which investigated the relationship between dairy 
consumption and several medical conditions. The medical 
conditions included were CHD, stroke and T2DM. 
We conducted our search in 2015, which was updated 
on February 07, 2016. We searched PubMed (1946 – 
Search Date) and EMBASE (1974–2016 February) via 
Ovid SP with no date/time, language, or document type 
limitation. Search terms were collected through experts’ 
                                                                                                     Arch Iran Med, Volume 21, Issue 5, May 2018  215
Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes through Adequate Dairy Consumption
opinion, literature review, and controlled vocabulary 
(Medical Subject Headings [MeSH] and Excerpta 
Medica Tree [EMTREE]). Search strategies developed 
by assistance of  a medical information specialist. The 
review included secondary research (meta-analyses and 
pooled analyses) that investigated the relation between 
consumption of  different types of  dairy foods among 
adults and the elderly population and incidences of 
the included medical conditions. We excluded all non-
human studies, narrative review articles, case reports, and 
editorials. Two methodologists selected the studies based 
on the study inclusion criteria. In case of  disagreement, 
a third reviewer reconciled the decision to make the final 
selection. We critically appraised the included studies 
using AMSTAR, a measurement tool to assess systematic 
reviews and meta-analysis studies. All included studies 
were summarized in narrative form and in summary 
tables that display the important features of  the studies 
including: outcomes, sample sizes, and incidence 
summary measures (Table 1). 
Step 2: Estimation of  Per Capita Dairy Consumption by 
Sex, Age and Dairy Food Subgroups 
Two important sources of  data were identified to be used 
for estimating average per capita dairy consumption. 
The first one is a survey conducted by Statistical Centre 
Figure 1. Study Phases’ Flowchart.
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of  Iran (SCI) for the last 2 decades. The SCI survey 
provides annual average dairy consumption. The dataset 
is nationally representative and presents the information 
on all different types of  dairy foods including milk, 
cheese, butter, yogurt and other forms of  dairy foods 
consumed in rural and urban households. Although the 
SCI food database provides detailed information on dairy 
consumption, it does not provide age- and sex-specific 
statistics on food consumption at the household-level. 
The second data source was a study conducted within 
the framework of  the Tehran Lipid and Glucose Study 
(TLGS), a large prospective cohort study that used a 
representative sample of  the Iranian urban population.31 
In the TLGS study, normal dietary intake was assessed 
using a 168-item food-frequency questionnaire (FFQ). 
The FFQ consists of  a list of  foods with a standard 
serving size. All participants in the study were asked to 
report the frequency of  consumption of  different types of 
foods during previous year on a daily, weekly and monthly 
basis. Dairy foods were classified into 3 groups including 
milk, yogurt and cheese according to the US Food Guide 
Pyramid. Since FFQ provides reasonably valid measures 
of  dairy consumption compared to the questionnaire 
used in the SCI survey, and given that data from the SCI 
is provided at the household-level while data from TLGS 
provides age- and sex specific data, we used the second 
dataset to estimate average per capita dairy consumption. 
Since the selected dataset is only representative of  the 
urban population (~70% of  all population), we adjusted 
the mean per capita dairy consumption in urban areas 
using the relative consumption reported in the SCI survey 
to estimate mean consumption level for rural population. 
Average dairy food consumption by sex, age and food are 
presented in Table 2. 
Step 3: Direct Healthcare Expenditure Associated With 
Included Diseases 
We obtained direct healthcare expenditure associated with 
diseases included in this study from previous local studies 
and medical expenditure registries in Iran. To estimate 
annual cost of  patients with T2DM, we used the most 
recent estimates by Javanbakht et al.4 They performed a 
Table 1. Selected Studies That Reported a Significant Association Between Dairy Consumption and Incidence of T2DM and CVD Diseases
Outcome Studies Included in Each Meta-Analysis Unit of RR RR (95% CI) Source
CHD 7 For <1.5 servings/day 0·88 (0·80–0·96) 20
CHD 9 For 1.5–3 servings/day 0·93 (0·85–1·00) 20
CHD 5 For >3 servings/day 0·86 (0·79–0·94) 20
Stroke 15 For <1.5 servings/day 0·92 (0·89–0·96) 20
Stroke 10 For >1.5 servings/day 0·91 (0·88–0·95) 20
T2DM 13 Per 200 g/d 0.94 (0.91–0.97) 20
Abbreviations: RR, relative risk; CHD, coronary heart diseases; T2DM, type 2 diabetes mellitus; g/d, gram/day.
Table 2. Dairy Foods Intake Per Person (g/d)
Age Group  Sex
Milk* Yogurt* Cheese*
Mean SD Mean SD Mean SD
1–9 
Male 269.7 341.6 189.1 245.8 22.1 24.6
Female 264.6 335.1 222.1 265.1 21.8 21.2
10–19 
Male 252.4 341.1 224.9 291.1 26.2 27.5
Female 213.4 322.7 231.2 300.9 23.0 24.7
20–29 
Male 169.0 254.9 228.7 281.5 24.5 26.0
Female 168.4 273.4 208.2 263.8 21.9 24.1
30–39 
Male 151.9 233.3 210.0 249.7 23.8 24.6
Female 180.1 279.2 211.8 257.9 25.1 24.2
40–49 
Male 136.5 220.6 201.1 238.1 24.8 21.4
Female 155.7 243.3 202.3 243.9 25.3 19.9
50–59 
Male 133.5 215.5 201.5 241.6 24.9 22.0
Female 164.7 264.5 195.8 231.3 24.7 18.9
60–69 
Male 147.1 232.5 187.7 213.7 24.9 21.2
Female 158.7 267.2 198.3 234.7 24.7 21.2
70+
Male 170.1 259.6 198.0 229.6 26.4 23.5
Female 146.7 226.0 182.7 200.0 25.4 20.0
* Includes all types of milk (i.e. low fat and high fat milk and chocolate milk);  all types of yogurt; all types of cheese.
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systematic literature review and Bayesian meta-analysis to 
estimate the cost of  patients with T2DM in Iran. They 
concluded that in 2009, the mean annual direct cost of 
patients with T2DM was US$556 (posterior standard 
deviation [PSD]: 221). 
To estimate the cost associated with CVD, a macro-
costing approach was taken because no national study 
was found in our search. Firstly, we defined relevant 
specific disease conditions that are included under the 
umbrella term CVD based on the International Disease 
Classification (ICD-10). These codes were (I20- I25) for 
CHD, (I10-I15) for hypertension and (I60-I69) for stroke. 
Secondly, using hospital information system registries, 
12 506 medical record files were extracted for patients 
who were admitted from March 2014 – September 2014 in 
6 main hospitals in 4 different provinces of  Iran (Tehran, 
Esfahan, Fars and Kurdistan, which account for 33% of 
the entire population in Iran). Thirdly, since our aim was 
to estimate the real cost of  healthcare from public and 
private perspective, and given that all selected hospitals 
were in the public sector (90% of  all hospital beds belong 
to public sector in Iran), we adjusted all hospital charges 
to reflect the real cost of  care. Fourthly, we calculated 
mean cost of  each episode of  hospitalization for each 
health condition using hospital admissions registry. A 
total annual inpatient cost was estimated separately for 
CHD, stroke and hypertension. Finally, as we aimed to 
estimate annual direct health expenditure per patient, 
we used the ratio of  inpatient cost to total direct cost to 
estimate total annual direct cost. Costs of  other diseases 
included in the study were obtained from previous 
studies (Table S1, Supplementary Materials). After 
summarizing the estimated average cost of  diseases, all 
costs were converted to US$ using an exchange rate (1$ 
equal to 32 000 Iranian Rial), and inflated to 2016 price 
using consumer price index in Iran.32
 
Step 4: Modelling 
After identifying the diseases that are significantly related 
to dairy consumption and estimating annual per capita 
cost, we built a Markov micro simulation (MM) model 
to predict the incidence of  each disease at current and 
optimal levels of  dairy consumption. The MM model is 
a computer modelling technique that simulates individual 
lives. The model uses person-level features including a 
unique identifier and a set of  associated attributes such 
as age, sex, level of  dairy consumption and disease 
condition. We applied a set of  transition probabilities 
and costs inputs in the models. The models used all the 
defined parameters and transition probabilities over many 
time steps and simulated individuals through the model 
one at a time and generated individual life histories of  a 
simulated population.33,34
CVD Model
We constructed our CVD MM model with 7 health states 
named: Healthy, hypertension, post stroke, CHD, CVD-
related death, net emigration and death from background 
mortality. Figure S1 ( see online Supplementary Materials ) 
shows the structure of  the CVD MM model. CHD health 
state includes patients with myocardial infarction and 
angina. A Markov model is a stochastic model describing 
a sequence of  possible events in which the probability 
of  each event depends only on the state attained in the 
previous event. Individual populations were simulated to 
pass through the model one at a time where they may 
exit because of  CVD-related or background death or net 
emigration. If  a case develops CVD, the model tracks 
disease progression in a cohort based on the defined 
transition probabilities.4 We obtained distribution of 
Iranian population in different age groups from the 
latest national census database.35 The most recent Iranian 
life table was used to estimate age- and sex-specific 
probability of  death from background mortality.36 Age- 
and sex-specific prevalence of  CVD and hypertension 
were taken from national health surveys and used as the 
initial distribution of  the simulated cohort in the Markov 
states.37–40 We used recent data provided by the national 
surveillance of  risk factors of  non-communicable 
diseases (SRFND) and other national studies to 
obtain age- and sex-specific incidence of  CVD.38,41 To 
estimate CVD incidence in the second arm (optimal 
dairy consumption), we linked the incidence rates to 
consumption level of  various dairy foods (Table S1, 
Supplementary Materials). Results from dose-response 
meta-analysis provided us with RR of  CVD incidence 
for different levels of  dairy consumption. We assumed 
that dairy consumption was protective if  only they were 
taken up to their recommended levels. 
When a CVD event happened, it was either fatal or 
non-fatal. We obtained age- and sex-specific probabilities 
of  having a fatal CVD event from an Iranian population-
based cohort study (population-based Isfahan Cohort 
Study (ICS)) which has reported fatal and nonfatal 
incidence rates of  IHD and stroke in a cohort of 
population in Iran based on 32,893 person-years of 
follow-up.41 We assumed that transitions across health 
states occur annually. The relevant annual costs assigned 
to each health state were based on the findings from phase 
3 of  the study. As we aimed to estimate total avoidable 
healthcare cost, we simulated a representative cohort 
sample of  entire Iranian male and female population 
from 2016. We estimated the expected avoidable cost 
using 1, 5, 10 and 20 years’ time-horizons. 
CVD Model Validation 
To assess validity of  the model, we followed the 
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International Society for Pharmacoeconomics and 
Outcomes Research (ISPOR) task force guideline.42 To 
validate the structure of  the CVD model, the models as 
well as input data and results were presented to an expert 
group of  health professionals to determine face validity. 
The group was asked to evaluate the model structure and 
assumptions in comparison to real world circumstances. 
We conducted a wide series of  sensitivity analyses to 
evaluate internal validity of  the CVD model. We assigned 
some null and extreme values for input parameters such 
as zero unit cost or probabilities and ran simulations 
separately for each validation scenario to compare results 
with base case values and to test the robustness of  the 
outputs. 
T2DM Model 
To estimate total avoidable healthcare cost associated with 
T2DM, we used the model which was already developed 
by the current study’s team. All details of  the model 
have been described elsewhere,4 in brief, the T2DM MM 
model contained 6 health states: Healthy, undiagnosed 
diabetes, diagnosed diabetes, net migration, diabetes-
related death and death from background mortality 
(Figure S2, Supplementary Materials). As per the CVD 
model, we linked the incidence of  T2DM to dairy foods 
consumption data which were incorporated into the 
T2DM MM model to estimate avoidable healthcare cost. 
 
Sensitivity Analysis
To explore parameter uncertainty in the model, we 
conducted probabilistic sensitivity analysis (PSA). To 
conduct PSA, we defined input parameters including 
costs and transition probabilities as statistical distributions 
in the model. Ranges and distributional assumptions for 
input parameters were based on the literature and nature 
of  the parameters. We ran the base-case analysis as 
probabilistic with a generation of  1000 trials within each 
individual level simulation. In other words, the model 
repeated the simulation 1000 times for each individual. 
Each time, the analysis drew the model parameters from 
the pre-specified probability distributions. We assigned 
beta distribution for transition probabilities, gamma 
distribution for cost, and log-normal distribution for RRs 
(Table S1, Supplementary Materials). We used TreeAge 
Pro 2014 software to construct and run all the models 
and the simulations.
Results
There were 287 records from PubMed and 429 records 
from EMBASE. After removing 181 duplicates, 2 
researchers screened 535 records based on title and 
abstract. 452 studies were excluded during screening, 
because they were irrelevant to our research question. 
Eighty-four studies were selected for full text assessment 
using inclusion and exclusion criteria. Finally12 
studies including 4 studies for diabetes.10,43–45 and 8 
for CVD,20,22,46–51 were included and appraised using 
AMSTAR tool. Process of  selection of  studies is shown 
in PRISMA flow diagram (Figure 2). Results from our 
systematic review indicated that T2DM, CHD and stroke 
were significantly associated with level of  dairy foods 
consumption.
 
T2DM 
After assessing all included studies for T2DM using the 
AMSATR tool, a study conducted by Gao et al10 was used 
to inform the T2DM model. Results from the T2DM 
model revealed a per capita savings of  $0.20, $5.93, $30.57 
and $142.56 within 1, 5, 10 and 20 years’ time horizon, 
respectively, due to a reduction in T2DM incidence by 
increasing dairy foods consumption to its optimum level. 
Total avoidable costs for all Iranian populations within 
the modelling time horizons were estimated to be $15.64, 
$465.78, $2400.13 and $11191.16 million, respectively. 
CVD 
Among included studies regarding relationship between 
CVD and dairy foods consumption, Alexander et al20 
was selected based on the AMSATR tool to inform the 
CVD model. The results showed that average avoidable 
per capita healthcare costs were $0.23, $2.49, $9.40 and 
$47.69 in 1, 5, 10 and 20-years’ time horizon, respectively, 
and corresponding total estimated avoidable costs among 
entire Iranian population were $18.19, $195.53, $738.08 
and $3743.47million, respectively. 
Total Avoidable Costs  
Including all avoidable costs from T2DM and CVD 
revealed that the introduction of  a diet containing 3 
servings of  dairy foods/day may produce a $0.43 saving 
in annual per capita healthcare cost in Iran in the first 
year. The estimated savings in per capita health cost were 
$8.42, $39.97 and $190.25 in 5, 10 and 20-years’ time 
horizon, respectively. Corresponding total aggregated 
avoidable cost for entire Iranian population within the 
study time horizons were $33.83, $661.31, $3138.21 
and $14934.63 million, respectively. A summary of  the 
estimations for all diseases can be found in Table 3. 
Discussion
Our analysis demonstrates significant reductions in 
healthcare cost that could be achieved by increasing 
consumption of  dairy foods to the recommended 
levels. Doidge et al52 conducted a study to estimate the 
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direct healthcare expenditure and burden of  disease 
(disability-adjusted life years [DALY]) attributable to 
low consumption of  dairy products in Australia. They 
found that in 2010–2011 financial year, AUD$2.0 billion 
(USD$2.1 billion, €1.6 billion, or 1.7% of  direct healthcare 
expenditure) and loss of  75,012 DALY were attributable 
to low dairy products consumption. McCarron et al53 
also undertook another study to estimate healthcare cost 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
For more information, visit www.prisma-statement.org. 
 
PRISMA 2009 Flow Diagram 
 
Records identified through 
database searching 
(n =  716 ) 
Sc
re
en
in
g 
In
clu
de
d 
El
ig
ib
ili
ty
 
Id
en
tif
ica
tio
n 
Records after duplicates removed 
(n =  181 ) 
Records screened 
(n = 535  ) 
Records excluded (title 
and abstract screening) 
(n =  452 ) 
Full-text articles assessed 
for eligibility 
(n =  84 ) 
72 full-text articles 
excluded 
Not reporting association 
between dairy products 
and including diseases, 
Editorials, letter to 
editors, Conference 
abstracts, review articles  
 (n = 72  ) 
12 studies included in 
study and assessed with 
AMSTAR tool 
8 CVD and hypertension 
4 T2DM 
2 studies that were reported a 
significant association between 
dairy products consumption and 
incidence of T2DM and CVD 
were selected to inform the 
disease models   
Figure 2. PRISMA Flow Diagram.
Table 3. Avoidable CVD and T2DM Healthcare Cost Through Adequate Dairy Intake in Iran
Time Horizon
Average Per Capita Cost (US$) Total Cost of Iranian Population (Million US$)
Current Intake Optimum Intake Difference Current Intake Optimum Intake Difference
Mean Mean Mean Mean
T2DM
1-year 95.32 95.12 0.2 7482.73 7467.10 15.64
5-years 507.53 501.59 5.93 39 840.78 39 375.00 465.78
10-years 1120.87 1090.29 30.57 87 988.27 85 588.14 2400.13
20-years 2690.25 2547.69 142.56 211 184.96 199 993.80 11 191.16
CVD
1-year 28.14 27.91 0.23 2209.03 2190.84 18.19
5-years 176.32 173.83 2.49 13 840.98 13 645.45 195.53
10-years 438.68 429.27 9.4 34 436.04 33 697.96 738.08
20-years 1078.05 1030.37 47.69 84 627.12 80 883.65 3,743.47
Total aggregated
1-year 123.46 123.03 0.43 9691.76 9657.94 33.83
5-years 683.85 675.42 8.42 53 681.76 53 020.45 661.31
10-years 1559.55 1519.56 39.97 122 424.31 119 286.10 3138.21
20-years 3768.30 3578.06 190.25 295 812.08 280 877.45 14 934.63
Abbreviations: CVD, cardiovascular disease; T2DM, type 2 diabetes mellitus.
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savings associated with adequate dairy foods intake in 
the United States. The results revealed that if  Americans 
increase their intake of  dairy foods to the currently 
recommended 3 to 4 servings/d, the projected first year 
savings would be approximately $26 billion, and 5-year 
cumulative savings would be in excess of  $200 billion.
Other studies have reported associations between 
dairy consumption and incidence of  some risk factors 
including hypertension12 and obesity,26,54 while we 
included only T2DM and CVD in our modeling. We 
included only direct medical cost in our estimations 
even though there are other indirect costs and health 
benefits to dairy consumption. However, including them 
would have increased the estimated avoidable cost. The 
indirect costs are related to increased productivity from a 
healthier workforce. Sensitivity analysis revealed that the 
results are more sensitive to mean annual cost of  diseases, 
diseases incidence rates and RR of  diseases incidence for 
different levels of  dairy foods intake. 
Like with all studies, several limitations exist that should 
be considered when interpreting the results. Firstly, due 
to limited longitudinal data, we assumed that some of 
the parameters used in our models were fixed over time, 
including disease incidence and dairy foods consumption. 
However, as time passes in the models, the cohorts become 
older and are at greater risk of  developing diseases. 
Moreover the base-case estimation was based on the 
PSA which means to estimate results we have accounted 
for any uncertainty in the parameters used in the models. 
Second, prediction of  avoidable future healthcare costs 
is related to current rates of  healthcare utilization and 
costs. In our model, we used the most recent estimates of 
per capita cost rates for modelled diseases. However, per 
capita healthcare cost and utilization may change over 
time, and future changes may influence the estimations. 
Third, although all included meta–analyses used 
analytical models that were harmonised based on similar 
exposures and similar outcome classifications, the data 
used in these studies were generated from observational 
studies. Therefore, the validity of  these meta-analyses is 
not guaranteed and may be biased, particularly because 
they are based on nutritional epidemiological studies 
where information bias is a dominant concern. Fourth, 
to present our models we classified different types of 
dairy foods into 3 main groups (milk, yogurt and cheese). 
Due to insufficient data, splitting results into high- and 
low-fat dairy foods was not possible, and this could 
be a source of  bias as quality of  dairy foods might be 
different across different countries. In addition, we did 
not have the distribution of  dairy consumption by age-
sex in rural areas. We assumed that the distribution is the 
same as that of  the urban areas. However there might be 
some differences between age and sex pattern of  dairy 
foods intake in the country. Given that rural population 
constitutes less than 30% of  the population in Iran, and 
it is unlikely that the pattern is hugely different from the 
urban areas, therefore we believe this could have minimal 
effect on the estimated costs. Finally, as we have modelled 
each disease separately, it is not possible to account for 
competing risks. Competing risks occur when patients 
can experience one or more events or outcomes which 
‘compete’ with the other outcomes of  interest. For 
example CVD patients that die due to a fatal CVD 
event have no chance for T2DM incidence; therefore 
there is no potential for saving T2DM healthcare cost 
through increased dairy consumption for those cases, 
though we believe this would have a minor effect on our 
estimations. Despite these limitations, using a systematic 
approach to find the most appropriate evidence and 
using local cost and sex- and age-specific epidemiologic 
and dairy consumption data in our analysis has made our 
results more applicable to local health policy-makers. We 
believe this method is the most solid and straightforward 
approach to assess the cost consequences of  reducing 
disease incidence through improved healthy diet which 
could be utilized to study similar research questions in 
other disease and risk factor areas. 
In conclusion, 2 of  the main questions that health 
policy-makers are faced with are how much health 
resources should be allocated to encourage the adoption 
of  a healthier diet and also what are the societal costs 
of  current deviations from the recommended diet. 
Estimation of  attributable cost to suboptimal dietary 
intake can help health policy-makers to understand 
where effective interventions might yield good returns 
and which policies and programs are cost effective that 
should be considered when defining a comprehensive 
and optimal plan of  care to control chronic diseases. 
Our findings strongly suggest that increasing dairy foods 
consumption to recommended levels would be associated 
with significant reductions in CVD and T2DM healthcare 
cost. Public health nutrition strategies should be directed 
to encourage people to consume more dairy foods. Also 
it should be mentioned that the analysis does not suggest 
that the entire Iranian population should consume the 
recommended levels of  dairy foods; it simply provides an 
estimate of  avoidable CVD and T2DM health care cost 
by increasing dairy consumption to the recommended 
levels. 
Authors’ Contribution
Conceived and designed the experiments: MJ, ARJ and HRB; 
Performed the study: MJ, ARJ, HRB AM, FS, MRH, RYB, HS, SD and 
AT; Analyzed the data: MJ, AM and. HRB; All authors discussed the 
results and contributed to the final manuscript.
Conflict of Interest Disclosures
The authors declare that they have no competing interests.
                                                                                                     Arch Iran Med, Volume 21, Issue 5, May 2018  221
Avoidable Health Care Costs of Cardiovascular Diseases and Type 2 Diabetes through Adequate Dairy Consumption
Ethical Statement
As this work consists of a review of previously published research 
no ethical approval was needed.
Funding
This research was supported by a grant from Rheumatology Research 
Center. No information used in preparation of this manuscript was 
owned by the sponsor.
Acknowledgements
The authors would like to thank kindly all advisors and colleagues, 
for their valuable technical support. We give our thanks to Ashkan 
Afshin, (University of Washington, USA), Fariba Kolahdooz 
(University of Alberta, Canada), Kamran Moradi (Tehran University 
of Medical Sciences, Iran), Mohammad Hossein Yarmohammadi 
and Mehdi Nasr (Isfahan University of Medical Sciences, Iran), and 
Bakhtiar Pirouzi (Sanandaj Hospital, Iran). 
Supplementary Materials
Online Supplementary data contain Table S1 and Figures S1-S2.
References 
1. Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi 
P, Pourmalek F, et al. Evaluating causes of death and morbidity 
in Iran, global burden of diseases, injuries, and risk factors study 
2010. Arch Iran Med. 2014;17(5):304-20. 
2. Daroudi R, Akbari Sari A, Nahvijou A, Kalaghchi B, Najafi M, 
Zendehdel K. The Economic Burden of Breast Cancer in Iran. 
Iran J Public Health. 2015;44(9):1225-33.
3. Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, 
Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 
2 diabetes mellitus in Iran. PLoS One. 2011;6(10):e26864. doi: 
10.1371/journal.pone.0026864.
4. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, 
Afshin A. Projection of Diabetes Population Size and Associated 
Economic Burden through 2030 in Iran: Evidence from Micro-
Simulation Markov Model and Bayesian Meta-Analysis. 
PLoS One. 2015;10(7):e0132505. doi: 10.1371/journal.
pone.0132505.
5. Bloom DE, Cafiero E, Jané – Llopis E, Abrahams – Gessel S, 
Bloom LR, Fathima S, et al. The global economic burden 
of noncommunicable diseases. Program on the Global 
Demography of Aging; 2012.
6. Global Burden of Disease: Country profiles: Iran. Institute for 
Health Metrics and Evaluation, University of Washington; 2015. 
Available from: http://www.healthdata.org/iran. 
7. Azadbakht L, Fard NR, Karimi M, Baghaei MH, Surkan PJ, 
Rahimi M, et al. Effects of the Dietary Approaches to Stop 
Hypertension (DASH) eating plan on cardiovascular risks 
among type 2 diabetic patients: a randomized crossover clinical 
trial. Diabetes Care. 2011;34(1):55-7. doi: 10.2337/dc10-0676.
8. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dairy 
consumption is inversely associated with the prevalence of 
the metabolic syndrome in Tehranian adults. Am J Clin Nutr. 
2005;82(3):523-30. doi: 10.1093/ajcn.82.3.523.
9. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey 
LP, Sacks FM, et al. A clinical trial of the effects of dietary 
patterns on blood pressure. DASH Collaborative Research 
Group. N Engl J Med. 1997;336(16):1117-24. doi: 10.1056/
nejm199704173361601.
10. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, et al. Dairy 
products consumption and risk of type 2 diabetes: systematic 
review and dose-response meta-analysis. PLoS One. 
2013;8(9):e73965. doi: 10.1371/journal.pone.0073965.
11. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products 
and the risk of type 2 diabetes: a systematic review and dose-
response meta-analysis of cohort studies. Am J Clin Nutr. 
2013;98(4):1066-83. doi: 10.3945/ajcn.113.059030.
12. Soedamah-Muthu SS, Verberne LD, Ding EL, Engberink 
MF, Geleijnse JM. Dairy consumption and incidence of 
hypertension: a dose-response meta-analysis of prospective 
cohort studies. Hypertension. 2012;60(5):1131-7. doi: 10.1161/
hypertensionaha.112.195206.
13. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman 
E, et al. Dairy products and colorectal cancer risk: a systematic 
review and meta-analysis of cohort studies. Ann Oncol. 
2012;23(1):37-45. doi: 10.1093/annonc/mdr269.
14. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, 
Engberink MF, Willett WC, et al. Milk and dairy consumption 
and incidence of cardiovascular diseases and all-cause 
mortality: dose-response meta-analysis of prospective cohort 
studies. Am J Clin Nutr. 2011;93(1):158-71. doi: 10.3945/
ajcn.2010.29866.
15. Dong JY, Zhang L, He K, Qin LQ. Dairy consumption and risk 
of breast cancer: a meta-analysis of prospective cohort studies. 
Breast Cancer Res Treat. 2011;127(1):23-31. doi: 10.1007/
s10549-011-1467-5.
16. Alonso A, Steffen LM, Folsom AR. Dairy intake and changes in 
blood pressure over 9 years: the ARIC study. Eur J Clin Nutr. 
2009;63(10):1272-5. doi: 10.1038/ejcn.2009.50.
17. Wang L, Manson JE, Buring JE, Lee IM, Sesso HD. Dietary 
intake of dairy products, calcium, and vitamin D and the risk of 
hypertension in middle-aged and older women. Hypertension. 
2008;51(4):1073-9. doi: 10.1161/hypertensionaha.107.107821.
18. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha 
D, et al. Effects on blood pressure of reduced dietary sodium 
and the Dietary Approaches to Stop Hypertension (DASH) diet. 
DASH-Sodium Collaborative Research Group. N Engl J Med. 
2001;344(1):3-10. doi: 10.1056/nejm200101043440101.
19. Miller GD, Jarvis JK, McBean LD. Handbook of Dairy Foods and 
Nutrition. CRC Press; 2006.
20. Alexander DD, Bylsma LC, Vargas AJ, Cohen SS, Doucette A, 
Mohamed M, et al. Dairy consumption and CVD: a systematic 
review and meta-analysis. Br J Nutr. 2016;115(4):737-50. doi: 
10.1017/s0007114515005000.
21. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Dairy foods and risk 
of stroke: a meta-analysis of prospective cohort studies. Nutr 
Metab Cardiovasc Dis. 2014;24(5):460-9. doi: 10.1016/j.
numecd.2013.12.006.
22. Soedamah-Muthu SS, Verberne LD, Ding EL, Engberink 
MF, Geleijnse JM. Dairy consumption and incidence of 
hypertension: a dose-response meta-analysis of prospective 
cohort studies. Hypertension. 2012;60(5):1131-7. doi: 10.1161/
hypertensionaha.112.195206.
23. McGrane MM, Essery E, Obbagy J, Lyon J, Macneil P, Spahn 
J, et al. Dairy Consumption, Blood Pressure, and Risk of 
Hypertension: An Evidence-Based Review of Recent Literature. 
Curr Cardiovasc Risk Rep. 2011;5(4):287-98. doi: 10.1007/
s12170-011-0181-5.
24. Gibson RA, Makrides M, Smithers LG, Voevodin M, Sinclair 
AJ. The effect of dairy foods on CHD: a systematic review of 
prospective cohort studies. Br J Nutr. 2009;102(9):1267-75. doi: 
10.1017/s0007114509371664.
25. Alonso A, Beunza JJ, Delgado-Rodriguez M, Martinez JA, 
Martinez-Gonzalez MA. Low-fat dairy consumption and 
reduced risk of hypertension: the Seguimiento Universidad de 
Navarra (SUN) cohort. Am J Clin Nutr. 2005;82(5):972-9. doi: 
10.1093/ajcn/82.5.972.
26. Kratz M, Baars T, Guyenet S. The relationship between high-fat 
dairy consumption and obesity, cardiovascular, and metabolic 
disease. Eur J Nutr. 2013;52(1):1-24. doi: 10.1007/s00394-012-
0418-1.
27. FAO. Food – based dietary guidelines – Iran 2015. Available 
from: http://www.fao.org/nutrition/education/food-based-
dietary-guidelines/regions/countries/iran/en/.
28. Committee DGA. Dietary Guidelines for Americans 2015-
2020. Government Printing Office; 2015.
29. Abdollahi M, Mohammadi-Nasrabadi F, Houshiarrad A, 
 Arch Iran Med, Volume 21, Issue 5, May 2018                                                        222
Javanbakht et al 
Ghaffarpur M, Ghodsi D, Kalantari N. Socio-economic 
Differences in Dietary Intakes: The Comprehensive Study on 
Household Food Consumption Patterns and Nutritional Status 
of I.R. Iran. Nutr Food Sci Res. 2014;1(1):19-26.
30. Mirmiran P, Hosseini-Esfahanil F, Jessri M, Mahan LK, Shiva 
N, Azizis F. Does dietary intake by Tehranian adults align 
with the 2005 dietary guidelines for Americans? Observations 
from the Tehran lipid and glucose study. J Health Popul Nutr. 
2011;29(1):39-52.
31. Azizi F, Madjid M, Rahmani M, Emami H, Mirmiran P, Hadjipour 
R. Tehran Lipid and Glucose Study (TLGS): rationale and design. 
Iran J Endocrinol Metab. 2000;2(2):77-86.
32. Iran CBo. Iran: Central Bank of Iran; 2015. Available fromhttp: //
www.cbi.ir/category/1611.aspx.
33. Rutter CM, Zaslavsky AM, Feuer EJ. Dynamic microsimulation 
models for health outcomes: a review. Med Decis Making. 
2011;31(1):10-8. doi: 10.1177/0272989x10369005.
34. Briggs A, Sculpher M, Claxton K. Decision Modelling for Health 
Economic Evaluation. Oxford University Press; 2006.
35. Implementation of the 2011 Iranian Population and Housing 
Census in Autumn. Statistical Centre of Iran; 2011. Available 
from: https://www.amar.org.ir/english/Population-and-Housing-
Censuses. 
36. Life tables by country Iran (Islamic Republic of). World Health 
Organization; 2013. Available from: http://apps.who.int/gho/
data/?theme=main&vid=60760. 
37. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of 
coronary heart disease among Tehran adults: Tehran Lipid and 
Glucose Study. East Mediterr Health J. 2009;15(1):157-66.
38. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, 
Haghazali M, Asgari F, et al. Third national Surveillance of 
Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) 
in Iran: methods and results on prevalence of diabetes, 
hypertension, obesity, central obesity, and dyslipidemia. BMC 
Public Health. 2009;9:167. doi: 10.1186/1471-2458-9-167.
39. Khalili D, Sheikholeslami FH, Bakhtiyari M, Azizi F, Momenan 
AA, Hadaegh F. The incidence of coronary heart disease 
and the population attributable fraction of its risk factors in 
Tehran: a 10-year population-based cohort study. PLoS One. 
2014;9(8):e105804. doi: 10.1371/journal.pone.0105804.
40. Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, 
Shishehbor MH, et al. Prevalence, awareness, treatment, and risk 
factors associated with hypertension in the Iranian population: 
the national survey of risk factors for noncommunicable 
diseases of Iran. Am J Hypertens. 2008;21(6):620-6. doi: 
10.1038/ajh.2008.154.
41. Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall 
T, Thomas GN, et al. Incidence of cardiovascular diseases in an 
Iranian population: the Isfahan Cohort Study. Arch Iran Med. 
2013;16(3):138-44. doi: 013163/aim.004.
42. Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson 
M, McCabe C, et al. Principles of good practice for decision 
analytic modeling in health-care evaluation: report of the ISPOR 
Task Force on Good Research Practices--Modeling Studies. 
Value Health. 2003;6(1):9-17.
43. Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson 
JE, Willett WC, et al. Dairy consumption and risk of type 2 
diabetes: 3 cohorts of US adults and an updated meta-analysis. 
BMC Med. 2014;12:215. doi: 10.1186/s12916-014-0215-1.
44. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products 
and the risk of type 2 diabetes: a systematic review and dose-
response meta-analysis of cohort studies. Am J Clin Nutr. 
2013;98(4):1066-83. doi: 10.3945/ajcn.113.059030.
45. Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption 
and risk of type 2 diabetes mellitus: a meta-analysis of cohort 
studies. Eur J Clin Nutr. 2011;65(9):1027-31. doi: 10.1038/
ejcn.2011.62.
46. Yakoob MY, Shi P, Hu FB, Campos H, Rexrode KM, Orav EJ, et al. 
Circulating biomarkers of dairy fat and risk of incident stroke in 
U.S. men and women in 2 large prospective cohorts. Am J Clin 
Nutr. 2014;100(6):1437-47. doi: 10.3945/ajcn.114.083097.
47. Elwood PC, Givens DI, Beswick AD, Fehily AM, Pickering 
JE, Gallacher J. The survival advantage of milk and dairy 
consumption: an overview of evidence from cohort studies 
of vascular diseases, diabetes and cancer. J Am Coll Nutr. 
2008;27(6):723s-34s.
48. Qin LQ, Xu JY, Han SF, Zhang ZL, Zhao YY, Szeto IM. Dairy 
consumption and risk of cardiovascular disease: an updated 
meta-analysis of prospective cohort studies. Asia Pac J Clin Nutr. 
2015;24(1):90-100. doi: 10.6133/apjcn.2015.24.1.09.
49. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Dairy foods and risk 
of stroke: a meta-analysis of prospective cohort studies. Nutr 
Metab Cardiovasc Dis. 2014;24(5):460-9. doi: 10.1016/j.
numecd.2013.12.006.
50. Soedamah-Muthu SS, Ding EL, Al-Delaimy WK, Hu FB, 
Engberink MF, Willett WC, et al. Milk and dairy consumption 
and incidence of cardiovascular diseases and all-cause 
mortality: dose-response meta-analysis of prospective cohort 
studies. Am J Clin Nutr. 2011;93(1):158-71. doi: 10.3945/
ajcn.2010.29866.
51. Elwood PC, Pickering JE, Hughes J, Fehily AM, Ness AR. Milk 
drinking, ischaemic heart disease and ischaemic stroke II. 
Evidence from cohort studies. Eur J Clin Nutr. 2004;58(5):718-
24. doi: 10.1038/sj.ejcn.1601869.
52. Doidge JC, Segal L, Gospodarevskaya E. Attributable risk 
analysis reveals potential healthcare savings from increased 
consumption of dairy products. J Nutr. 2012;142(9):1772-80. 
doi: 10.3945/jn.111.154161.
53. McCarron DA, Heaney RP. Estimated healthcare savings 
associated with adequate dairy food intake. Am J Hypertens. 
2004;17(1):88-97.
54. Dror DK. Dairy consumption and pre-school, school-age and 
adolescent obesity in developed countries: a systematic review 
and meta-analysis. Obes Rev. 2014;15(6):516-27. doi: 10.1111/
obr.12158.
55. Fact sheet of Iran STEPS Survey 2009 Tehran, Iran. Iran Minstry 
of Health; 2009. Available from: http://www.ncdinfobase.ir/
english/docs.asp. 
56. Sadeghi M, Ruhafza H, Shirani S, Akhavan Tabib A, Aghdak P, 
Hosseini S. The prevalence of coronary artery disease according 
to Rose questionnaire and ECG: Isfahan Healthy Heart Program 
(IHHP). ARYA Journal. 2006;2(2):70-74. doi: 10.22122/arya.
v2i2.149.
                    © 2018 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.
org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
